Europe — EMA
Lamivudin Aurobindo
GNH USA supplies Lamivudin Aurobindo (Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV infection and chronic hepatitis B.
Request sourcing
What is Lamivudine?
Lamivudine, the active ingredient in Lamivudin Aurobindo, is a nucleoside reverse transcriptase inhibitor (NRTI) presented as an oral tablet for oral use. It treats HIV infection and chronic hepatitis B in adults and children as prescribed.
GNH USA supplies Lamivudin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Lamivudine used for?
Lamivudin Aurobindo is used in the management of viral infections that target the reverse transcriptase pathway.
- HIV infection: reduces viral load and helps restore immune function. - Chronic hepatitis B: suppresses viral replication and improves liver enzyme levels. - HIV/HBV co‑infection: provides simultaneous control of both viruses in patients with dual infection.
What are the side effects of Lamivudine?
Lamivudin Aurobindo may cause a range of adverse reactions. Most are mild and reversible, but serious events can occur.
Common Side Effects: - Nausea - Headache - Fatigue - Diarrhea - Insomnia - Abdominal pain
Serious or Rare Side Effects: - Lactic acidosis - Severe hepatotoxicity - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Pancreatitis - Severe hypersensitivity reactions - Grade 3–4 neutropenia or anemia
What precautions apply to Lamivudine?
Lamivudin Aurobindo requires careful monitoring and patient counseling to minimise risks. - Liver function monitoring: assess baseline enzymes and repeat periodically. - Renal function assessment: adjust dose in severe impairment. - HBV reactivation watch: monitor hepatitis B surface antigen in patients discontinuing therapy. - Adherence counseling: emphasize the importance of consistent dosing to prevent resistance. - Hypersensitivity avoidance: discontinue if severe rash or anaphylaxis occurs. - Store at below 25°C: keep in the original pack, protect from moisture.
What does Lamivudine interact with?
Lamivudin Aurobindo can interact with several antiretroviral and non‑antiretroviral agents.
Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: heightened mitochondrial toxicity. - Ribavirin: enhanced hematologic toxicity.
Moderate Interactions (Monitor Closely): - Efavirenz: possible reduction in lamivudine plasma levels. - Nevirapine: potential liver enzyme elevation. - Alcohol: may exacerbate hepatic adverse effects.
Frequently asked questions
What is Lamivudin Aurobindo used for?+
How does lamivudine work?+
What is the usual dose of lamivudine?+
Is lamivudine safe during pregnancy or breastfeeding?+
How do I order Lamivudin Aurobindo from GNH USA?+
How does lamivudine compare with other antiretroviral drugs?+
What are the storage and handling requirements for Lamivudin Aurobindo?+
How is Lamivudin Aurobindo administered?+
What are the most serious risks associated with lamivudine?+
Who should not use Lamivudin Aurobindo?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo